SymbolCLNN
NameCLENE INC.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Pharmaceutical Preparations
Address6550 SOUTH MILLROCK DRIVE,SUITE G50, SALT LAKE CITY, Utah, 84121, United States
Telephone+1 801 - 676-9695
Fax
Email
Websitehttps://www.clene.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001822791
Description

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).

Additional info from NASDAQ:
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).

2026-07-29 12:30

Clene to Present at The Canaccord 46th Annual Growth Conference

Read more
2026-06-15 18:24

Mortenson Mark 🟢 acquired 45.0K shares (1 derivative) of Clene Inc. (CLNN) at $5.53 Transaction Date: Jun 11, 2026 | Filing ID: 020637

Read more
2026-06-15 18:23

Director Etherington Robert Dee 🟢 acquired 65.0K shares (1 derivative) of Clene Inc. (CLNN) at $5.53 Transaction Date: Jun 11, 2026 | Filing ID: 020636

Read more
2026-06-15 18:22

BROWN MORGAN R 🟢 acquired 15.0K shares (1 derivative) of Clene Inc. (CLNN) at $5.53 Transaction Date: Jun 11, 2026 | Filing ID: 020635

Read more
2026-06-05 17:10

New Form S-8 - Clene Inc. <b>Filed:</b> 2026-06-05 <b>AccNo:</b> 0001437749-26-019742 <b>Size:</b> 195 KB

Read more
2026-05-22 20:37

(99% Neutral) CLENE INC. (CLNN) Announces Executive Changes

Read more
2026-05-22 18:03

Director McLaughlin Vallerie 🟢 acquired 3.6K shares (2 derivative) of Clene Inc. (CLNN) at $6.81 Transaction Date: May 21, 2026 | Filing ID: 018221

Read more
2026-05-22 18:02

Director Desai Arjun JJ 🟢 acquired 3.7K shares (2 derivative) of Clene Inc. (CLNN) at $6.81 Transaction Date: May 21, 2026 | Filing ID: 018220

Read more
2026-05-22 18:02

Director Mosca Alison 🟢 acquired 4.4K shares (2 derivative) of Clene Inc. (CLNN) at $6.81 Transaction Date: May 21, 2026 | Filing ID: 018219

Read more
2026-05-22 17:58

Director MATLIN DAVID J 🟢 acquired 5.2K shares (2 derivative) of Clene Inc. (CLNN) at $6.81 Transaction Date: May 21, 2026 | Filing ID: 018218

Read more